TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,405,116 | +4.1% | 1,512,936 | +5.7% | 0.01% | +10.0% |
| Q2 2023 | $22,491,515 | +16.6% | 1,431,669 | -69.5% | 0.01% | +11.1% |
| Q1 2023 | $19,281,714 | +11.7% | 4,699,603 | +324.8% | 0.01% | 0.0% |
| Q4 2022 | $17,258,540 | +49.5% | 1,106,317 | +24.3% | 0.01% | +28.6% |
| Q3 2022 | $11,542,000 | +45.6% | 889,872 | +57.6% | 0.01% | +75.0% |
| Q2 2022 | $7,927,000 | +11.4% | 564,610 | +13.6% | 0.00% | 0.0% |
| Q1 2022 | $7,117,000 | +21.8% | 497,000 | +15.9% | 0.00% | +33.3% |
| Q4 2021 | $5,845,000 | -17.7% | 428,834 | -1.1% | 0.00% | -25.0% |
| Q3 2021 | $7,102,000 | +2.4% | 433,558 | +5.2% | 0.00% | 0.0% |
| Q2 2021 | $6,933,000 | -15.1% | 411,958 | -7.8% | 0.00% | -20.0% |
| Q1 2021 | $8,163,000 | +4.7% | 447,023 | +4.3% | 0.01% | -16.7% |
| Q4 2020 | $7,797,000 | +21.4% | 428,416 | +19.0% | 0.01% | 0.0% |
| Q3 2020 | $6,423,000 | -0.4% | 360,019 | +0.1% | 0.01% | 0.0% |
| Q2 2020 | $6,451,000 | +19.5% | 359,769 | +1.2% | 0.01% | 0.0% |
| Q1 2020 | $5,397,000 | -9.1% | 355,535 | +18.2% | 0.01% | 0.0% |
| Q4 2019 | $5,935,000 | +22.4% | 300,803 | +6.7% | 0.01% | +20.0% |
| Q3 2019 | $4,848,000 | +8.0% | 281,836 | +11.2% | 0.01% | -16.7% |
| Q2 2019 | $4,487,000 | +11.1% | 253,518 | +27.8% | 0.01% | 0.0% |
| Q1 2019 | $4,040,000 | +117.3% | 198,331 | +79.4% | 0.01% | +100.0% |
| Q4 2018 | $1,859,000 | – | 110,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |